Showing results (531-540 of 715) with videos related to

Sort By:
Pageof 72
Gene|November 8, 2017
Evaluation of PCSK9 levels and its genetic polymorphisms in women with polycystic ovary syndromeLuana B Xavier, Mirelle O Sóter, Mariana F Sales, et al.
Arquivos Brasileiros De Cardiologia|February 7, 2001
Total agenesis of the left pericardiumJ G Lobo Filho, R R Oliveira, R P de Siqueira, et al.
Cytogenetic and Genome Research|December 24, 2010
Chromosomal homologies among vampire bats revealed by chromosome painting (phyllostomidae, chiroptera)C G Sotero-Caio, J C Pieczarka, C Y Nagamachi, et al.
Diabetology & Metabolic Syndrome|June 10, 2010
Algorithm for the treatment of type 2 diabetes: a position statement of Brazilian Diabetes SocietyAntonio C Lerario, Antonio R Chacra, Augusto Pimazoni-Netto, et al.
Plos One|May 24, 2014
Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsiaLuiza O Perucci, Karina B Gomes, Letícia G Freitas, et al.
Accounts of Chemical Research|October 13, 2009
Ligand binding and hydration in protein misfolding: insights from studies of prion and p53 tumor suppressor proteinsJerson L Silva, Tuane C R G Vieira, Mariana P B Gomes, et al.
Bioorganic & Medicinal Chemistry|April 14, 2022
Insights into the anticancer activity of chiral alkylidene-β-lactams and alkylidene-γ-lactams: Synthesis and biological investigationAmérico J S Alves, Nuno G Alves, Mafalda Laranjo, et al.
Polymers|October 13, 2021
Mussel-Inspired Catechol Functionalisation as a Strategy to Enhance Biomaterial Adhesion: A Systematic ReviewPedro M Costa, David A Learmonth, David B Gomes, et al.
Transplantation Proceedings|August 16, 2006
Serologic profile in hepatitis B virus and hepatitis C virus in a Brazilian liver transplant waiting listR A M B Almeida, G F Silva, J C Llanos, et al.
Diabetes, Obesity & Metabolism|July 2, 2021
What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second-line therapy? Results from the DISCOVER studyFabrice Bonnet, Hungta Chen, Andrew Cooper, et al.
Pageof 72